Lifesci Capital Lowers Inhibrx (NASDAQ:INBX) to Market Perform
Lifesci Capital downgraded shares of Inhibrx (NASDAQ:INBX – Free Report) from an outperform rating to a market perform rating in a report issued on Tuesday morning, PriceTargets.com reports. Separately, JMP Securities reaffirmed a market perform rating on shares of Inhibrx in a research report on Tuesday. View Our Latest Research Report on INBX Inhibrx Stock […]
More Stories
Heritage NOLA Bancorp (OTCMKTS:HRGG) Shares Up 2.4% – What’s Next?
Shares of Heritage NOLA Bancorp, Inc. (OTCMKTS:HRGG – Get Free Report) rose 2.4% on Thursday . The stock traded as...
International Container Terminal Services (OTCMKTS:ICTEF) Trading Up 9.5% – Time to Buy?
International Container Terminal Services, Inc. (OTCMKTS:ICTEF – Get Free Report)’s share price rose 9.5% during trading on Thursday . The...
Overlay Shares Large Cap Equity ETF (NYSEARCA:OVL) Stock Price Up 0.1% – Here’s What Happened
Overlay Shares Large Cap Equity ETF (NYSEARCA:OVL – Get Free Report) shares rose 0.1% on Thursday . The stock traded...
Sidoti Csr Issues Negative Estimate for Xcel Brands Earnings
Xcel Brands, Inc. (NASDAQ:XELB – Free Report) – Research analysts at Sidoti Csr decreased their Q3 2025 earnings per share...
DA Davidson Forecasts Toro’s Q1 Earnings (NYSE:TTC)
The Toro Company (NYSE:TTC – Free Report) – Analysts at DA Davidson issued their Q1 2025 earnings per share (EPS)...
Sidoti Csr Analysts Raise Earnings Estimates for USNA
USANA Health Sciences, Inc. (NYSE:USNA – Free Report) – Research analysts at Sidoti Csr boosted their Q1 2026 earnings per...